Key indicators: single-crystal X-ray study; T = 293 K; mean (C-C) = 0.007 Å; R factor = 0.046; wR factor = 0.109; data-to-parameter ratio = 7.5.
In the title compound, C 6 H 6 ClN 3 O 2 , all non-H atoms are approximately coplanar [maximum deviation = 0.012 (4) Å ]; an intramolecular N-HÁ Á ÁO hydrogen bond occurs between the amino group and the carbonyl group. In the crystal, molecules are linked by N-HÁ Á ÁN hydrogen bonds into supramolecular chains propagated along [101] .
Related literature
For related structures, see: He & Kang (2006) ; He et al. (2007) . For the synthesis, see: Ballard & Johnson (1942) .
Experimental
Crystal data 
Data collection
Enraf-Nonius CAD-4 diffractometer 1474 measured reflections 817 independent reflections 673 reflections with I > 2(I) Table 1 Hydrogen-bond geometry (Å , ). The title compound,(I), is an intermediate for preparation of tuberculosis. We herein report its crystal structure.
The molecular structure of (I) is shown in Fig. 1 . The bond lengths and angles are within normal ranges (He & Kang, 2006; He et al., 2007) . The pyrimidine ring is almost planar.
In the crystal, molecules are linked each other to form chains framework via intermolecular N-H···N hydrogen bonds, which with intramolecular N-H···O hydrogen bonds may be effective in the stabilization of the crystal structure.
S2. Experimental
The title compound was synthesized according to the reported procedure (Ballard & Johnson, 1942) . Crystals suitable for X-ray analysis were obtained by dissolving it (0.5 g) in dichloromethane (50 ml) and evaporating the solvent slowly at room temperature for about 5 d.
S3. Refinement
H atoms were positioned geometrically with N-H = 0.86 and C-H = 0.93-0.96 Å, and refined in riding mode, U iso (H) = 1.5U eq (C) for methyl H atoms and 1.2U eq (C,N) for the others.
Figure 1
The molecular structure of (I), with the atom-numbering scheme. Displacement ellipsoids are drawn at the 50% probability level. A packing diagram of (I).
Methyl 4-amino-2-chloropyrimidine-5-carboxylate
